Covered recipient · General Payments record
OLIVER J OATMAN
Allopathic & Osteopathic Physicians Pediatrics Pediatric Endocrinology
General Payments · PY2018–2024
$2,001.81
- Reported across 103 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $391.33 | 16 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| BETA BIONICS, INC. | $158.78 | 4 |
| ABBVIE INC. | $65.63 | 4 |
| Ascensia Diabetes Care US Inc. | $35.80 | 2 |
| Medtronic, Inc. | $32.45 | 1 |
| Xeris Pharmaceuticals, Inc. | $23.73 | 1 |
| Rhythm Pharmaceuticals, Inc. | $23.46 | 1 |
| PFIZER INC. | $19.28 | 1 |
| Ascendis Pharma Inc | $16.59 | 1 |
| Novo Nordisk AS | $15.61 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $16.34 | 01/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142698 | CMS |
| ABBVIE INC. | $17.12 | 03/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142700 | CMS |
| ABBVIE INC. | $18.93 | 04/10/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142702 | CMS |
| ABBVIE INC. | $13.24 | 11/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105142704 | CMS |
| Ascendis Pharma Inc | $16.59 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1133845467 | CMS |
| Ascensia Diabetes Care Us Inc. | $15.13 | 10/31/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089094165 | CMS |
| Ascensia Diabetes Care Us Inc. | $20.67 | 12/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1089094167 | CMS |
| BETA BIONICS, INC. | $43.30 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087878121 | CMS |
| BETA BIONICS, INC. | $2.95 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087880685 | CMS |
| BETA BIONICS, INC. | $31.79 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087880761 | CMS |
| BETA BIONICS, INC. | $80.74 | 08/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1087880775 | CMS |
| Medtronic, Inc. | $32.45 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1119484042 | CMS |
| Novo Nordisk Inc | $15.61 | 08/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097509327 | CMS |
| PFIZER INC. | $19.28 | 06/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131682783 | CMS |
| Rhythm Pharmaceuticals, Inc. | $23.46 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141480548 | CMS |
| Xeris Pharmaceuticals, Inc. | $23.73 | 03/27/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1144608161 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2021, 2022, 2023, 2024
- Source files
- Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.